AXEL Gliderssp. z o.o.

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2013-05-29
Share capital
6,000.00 PLN
Registered address
Wojska Polskiego 9, 39-300 Mielec, Poland

Financials

Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.

Revenue history

Filing timeliness

No financial statement for 2023 – the filing deadline has passed. 5 of 5 financial statements were filed late (the longest delay 1085 days for 2019).

  • 2023not filed
  • 202205/10/2023
  • 202105/10/2023
  • 202005/10/2023
  • 201905/10/2023
  • 201809/11/2019
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Authorized Representatives

Paweł Jan Świerczyńskiage 46 – President of the Management Board

Manner of representation

In the case of a multi-member management board, declarations of will on behalf of the company require the joint action of two members of the management board or one member of the management board jointly with a commercial proxy. The management board is competent to make declarations of will concerning rights and obligations on behalf of the company, whereas in the case of a multi-member management board, each member of the management board acting independently is authorised in respect of rights and obligations whose value does not exceed PLN 100,000.00. However, disposing of a right or incurring obligations above the stated amount requires the joint action of two members of the management board or one member of the management board jointly with a commercial proxy.

Ownership

OwnerSharesShare valueStake
20$540.2533.3333%
20$540.2533.3333%
20$540.2533.3333%

Beneficial owners

No beneficial owners recorded for the company AXEL Gliders.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

Competitors

FAQ

Last updated: 2026-04-26